2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
10
Neoplasms
9
Marijuana Abuse
5
Cancer Pain
5
Glioblastoma
2
Squamous Cell Carcinoma of Head and Neck
1
Signs and Symptoms
1
Recurrence
1
Parasomnias
1
Pancreatic Neoplasms
1
Neuralgia
1
Nausea
1
Multiple Sclerosis
1
Mouth Neoplasms
1
Marijuana Use
1
Diabetes Mellitus
1
Chronic Pain
1
Cachexia
1
Breast Neoplasms
1
Brain Neoplasms
1
Anxiety Disorders
1
Anorexia
1
Advanced Malignant Solid Tumor
1
Advanced Cancer
1
1- Cancer Patients During Chemotherapy Treatment
1
Interventions
Surveys and Questionnaires
6
Melatonin
4
Yoga
2
Exercise
2
Control Groups
2
nabiximols
1
Walking
1
Ultraviolet Therapy
1
Tai Ji
1
Sugars
1
Respiration
1
Relaxation Therapy
1
Qigong
1
Modafinil
1
Minocycline
1
Mindfulness
1
Midazolam
1
Massage
1
Intensive Care Units
1
Exercise Movement Techniques
1
Dronabinol
1
Cannabidiol
1
Breathing Exercises
1
Autogenic Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parasomnias
×
nabiximols
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled